SCHEMBL7974853

SCHEMBL7974853

Oc1nc(-c2ccccc2Cl)nc2ncn(Cc3ccccc3)c12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.48
SMN1; SMN2 Q16637 4/20 0.42
ALDH1A1 P00352 3/20 0.42
HPGD P15428 1/20 0.40
GAA P10253 2/20 0.40
P2RX7 Q99572 2/20 0.40
KMT2A Q03164 1/20 0.39
GBA1 P04062 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C19 P33261 1/20 0.39
NR1H2 P55055 1/20 0.39
NR1H3 Q13133 1/20 0.39
PARN O95453 1/20 0.38
CNOT7 Q9UIV1 1/20 0.38
TNF P01375 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985538 0.89 SMN1; SMN2 (0.43) DPP4SMN1; SMN2ALDH1A1HPGDGAA
SCHEMBL7985801 0.88 CXCR2 (0.41) DPP4SMN1; SMN2ALDH1A1HPGDGAA
SCHEMBL7974646 0.86 MAPK14 (0.47) DPP4SMN1; SMN2ALDH1A1HPGDGAA
SCHEMBL7975267 0.84 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1HPGDGAAKMT2A
SCHEMBL7975122 0.83 GAA (0.46) SMN1; SMN2ALDH1A1HPGDGAAP2RX7
SCHEMBL7984459 0.82 NR1H2 (0.43) SMN1; SMN2ALDH1A1HPGDGAAKMT2A
SCHEMBL7985492 0.82 SMN1; SMN2 (0.42) SMN1; SMN2ALDH1A1HPGDKMT2APARN
SCHEMBL7988558 0.81 SMN1; SMN2 (0.43) SMN1; SMN2ALDH1A1HPGDGAAKMT2A
SCHEMBL7991405 0.80 CYP11B1 (0.45) SMN1; SMN2ALDH1A1HPGDKMT2AMAPK1
SCHEMBL7974441 0.80 GRK2 (0.43) SMN1; SMN2ALDH1A1HPGDGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed